Dr. Anna Pavlick on Dendritic Cells vs Montanide in Melanoma Patients in Remission

Source: Cancer Network , July 2019

Cancer Network spoke with Anna Pavlick, MD, of NYU Langone Health, on the results of a phase II study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared with Montanide in melanoma patients in complete clinical remission. The data were presented at ASCO 2019.